Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial

Mukul Sharma, Carlos A. Molina, Ḱazunori Toyoda, Dániel Bereczki, Shrikant I. Bangdiwala, Scott E. Kasner, Helmi L. Lutsep, Georgios Tsivgoulis, George Ntaios, Anna Członkowska, Ashfaq Shuaib, Pierre Amarenco, Matthias Endres, Byung‐Woo Yoon, David Tanné, Danilo Toni, Laetitia Yperzeele, Paul von Weitzel‐Mudersbach, Gisele Sampaio Silva, Álvaro Avezum, Jesse Dawson, Daniel Strbian, Turgut Tatlisumak, Jens Eckstein, Sebastián F. Ameriso, Joerg R. Weber, Else Charlotte Sandset, Nana Goar Pogosova, Pablo M Lavados, Antonio Araúz, David Gailani, Hans‐Christoph Diener, Richard A. Bernstein, Charlotte Cordonnier, Anja Kahl, Grigor Abelian, Mark Donovan, Chahin Pachaï, Danshi Li, Graeme J. Hankey